Mannkind (MNKD) Other Operating Expenses (2014 - 2026)
Mannkind (MNKD) reported Other Operating Expenses of $20.5 million for Q1 2026, up 2.48% year-over-year from $20.0 million in Q1 2025, and down 39.0% quarter-over-quarter from $33.6 million in Q4 2025.
Mannkind (MNKD) Other Operating Expenses (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Other Operating Expenses data on file, last reported at $20.5 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $20.5 million, up 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $100.2 million (up 32.65% YoY), and the FY2025 annual result was -$27.1 million, up 52.89% from the prior year.
- Other Operating Expenses eased to $20.5 million in Q1 2026 per MNKD's latest filing, from $33.6 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $33.6 million in Q4 2025 and troughed at -$28.8 million in Q2 2022.
- A 5-year average of $5.7 million and a median of $17.2 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses slumped 782.42% in 2022, then surged 476.98% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at -$17.9 million in 2022, then declined by 10.93% to -$19.9 million in 2023, then soared by 176.2% to $15.2 million in 2024, then surged by 121.76% to $33.6 million in 2025, then sank by 39.0% to $20.5 million in 2026.
- Business Quant data shows MNKD's Other Operating Expenses at $20.5 million in Q1 2026, $33.6 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.52 Mn |
| Dec 31, 2025 | 33.64 Mn |
| Sep 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 25.93 Mn |
| Mar 31, 2025 | 20.03 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 20.48 Mn |
| Jun 30, 2024 | 19.85 Mn |
| Mar 31, 2024 | 17.20 Mn |
| Dec 31, 2023 | -19.91 Mn |
| Sep 30, 2023 | 25.63 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -17.95 Mn |
| Sep 30, 2022 | -14.12 Mn |
| Jun 30, 2022 | -28.76 Mn |
| Mar 31, 2022 | -25.74 Mn |
| Dec 31, 2021 | -27.80 Mn |
| Sep 30, 2021 | -4.26 Mn |
| Jun 30, 2021 | -35.55 Mn |